Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/2010
09/02/2010WO2010028066A3 Cd133 epitopes
09/02/2010WO2010006059A8 Prostaglandin e2 binding proteins and uses thereof
09/02/2010WO2008104979A3 Nuclear targeting sequences
09/02/2010US20100223678 protein isoforms of the pif-family and uses thereof
09/02/2010US20100222555 Monoclonal antibodies that neutralize botulinum neurotoxin
09/02/2010US20100222237 Methods for Generating Polynucleotides Having Desired Characteristics by Iterative Selection and Recombination
09/02/2010US20100222234 Malaria antigen screening method
09/02/2010US20100221822 Humanized and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
09/02/2010US20100221761 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
09/02/2010US20100221746 Compositions and methods for the treatment of disease
09/02/2010US20100221720 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
09/02/2010US20100221357 Drug delivery product and methods
09/02/2010US20100221349 Nucleic acid constructs
09/02/2010US20100221343 Compositions and methods of making brittle-matrix particles through blister pack freezing
09/02/2010US20100221314 Microneedle Device
09/02/2010US20100221290 Mixed haptenized tumor cells and extracts and methods of treating or screening for cancer
09/02/2010US20100221289 Method for treating stage iv melanoma
09/02/2010US20100221288 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
09/02/2010US20100221287 Streptococcus pneumoniae Polynucleotides and Sequences
09/02/2010US20100221286 Modified live aeromonas hydrophila vaccine for aquatic animals
09/02/2010US20100221285 Method of Immunization Against the 4 Dengue Serotypes
09/02/2010US20100221284 Novel vaccine composition
09/02/2010US20100221283 Circovirus sequences associated with piglet weight loss disease (pwd)
09/02/2010US20100221282 Recombinant vaccine against west nile virus
09/02/2010US20100221281 High molecular weight polysaccharide that binds and inhibits virus
09/02/2010US20100221280 Plant-produced compositions for treating papillomavirus infection and related methods
09/02/2010US20100221279 Kennel cough vaccine
09/02/2010US20100221278 Immunogenic compositions for streptococcus pyogenes
09/02/2010US20100221277 Chlamydia pneumoniae antigens
09/02/2010US20100221276 Circovirus sequences associated with piglet weight loss disease (pwd)
09/02/2010US20100221275 Protection of an animal against pestivirus infection
09/02/2010US20100221274 Method of administering a thymosin alpha 1 peptide
09/02/2010US20100221273 Treatment of viral infections
09/02/2010US20100221272 Immunomodulatory compositions and methods for treating disease with modified host defense peptides
09/02/2010US20100221271 Nucleic Acid and Amino Acid Sequences, and Vaccine for the Control of Ectoparasite Infestations in Fish
09/02/2010US20100221270 Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
09/02/2010US20100221269 Synthetic lipid a derivative
09/02/2010US20100221268 T cell immunomodulation by placenta cell preparations
09/02/2010US20100221267 Pdgfr beta-specific inhibitors
09/02/2010US20100221266 Methods to regulate mirna processing by targeting lin-28
09/02/2010US20100221265 Immune modulation via c-type lectin
09/02/2010US20100221264 Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein
09/02/2010US20100221263 Anti-Sclerostin Antibodies
09/02/2010US20100221262 Anti-unc5b antibodies and methods of use
09/02/2010US20100221261 Iap bir domain binding compounds
09/02/2010US20100221260 Immunoglobulins
09/02/2010US20100221259 Nitrogen-containing heterocyclic compounds and medicinal use thereof
09/02/2010US20100221258 Method of treating a pathological syndrome and a pharmaceutical agent
09/02/2010US20100221257 Binding members-513
09/02/2010US20100221256 Meningococcus adhesins nada, app and orf 40
09/02/2010US20100221255 Apelin peptides and methods of use
09/02/2010US20100221254 Methods and Compositions for PDGF-C Activation and Inhibition
09/02/2010US20100221253 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use
09/02/2010US20100221252 Mdl-1 uses
09/02/2010US20100221251 Compositions and Methods for Treatment of Cancer
09/02/2010US20100221250 Methods of treating brain tumors with antibodies
09/02/2010US20100221249 Wisp polypeptides and nucleic acids encoding same
09/02/2010US20100221248 Directed Engagement of Activating Fc Receptors
09/02/2010US20100221247 Agents and methods for treatment of cancer
09/02/2010US20100221246 Methods and compositions for treating cancer
09/02/2010US20100221245 Topical skin care composition
09/02/2010US20100221244 Antagonizing signal transduction in dorsal root ganglion cells in a subject with il-31 antagonists
09/02/2010US20100221243 Methods and compositions for the treatment and diagnosis of diseases characterized by vascular leak, hypotension, or a procoagulant state
09/02/2010US20100221242 Anti-viral griffithsin compounds, compositions and methods of use
09/02/2010US20100221241 Constrained hiv envelope-based immunogen that simultaneously presents receptor and coreceptor binding sites
09/02/2010US20100221240 Chemically Modified Peptide Analogs
09/02/2010US20100221227 Novel method of treating disease
09/02/2010US20100221223 Immune response induction method
09/02/2010US20100221221 N-phenyl-2-pyrimidineamine derivatives
09/02/2010US20100221219 Compositions for treating multiple sclerosis
09/02/2010US20100221216 Hepatitis c virus inhibitors
09/02/2010US20100221215 Linked dibenzimidazole derivatives
09/02/2010US20100221214 Linked dibenzimidazole derivatives
09/02/2010US20100221212 Proproteins and methods of use thereof
09/02/2010US20100221211 Pyridone-substituted-dihydropyrazolopyrimidinone derivative
09/02/2010US20100221208 Treatment and Diagnostic Methods for Fibrosis Related Disorders
09/02/2010US20100221187 Treatment of amyloidogenic diseases
09/02/2010US20100221186 Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds
09/02/2010US20100221185 Vaccines and vaccine components for inhibition of microbial cells
09/02/2010US20100221183 Peptides for treating and diagnosing cancers and methods for using the same
09/02/2010US20100221179 IL-1 Binding Proteins
09/02/2010US20100221178 Method for Treating the TH2-Mediated Disease
09/02/2010US20100221177 RS7 Antibodies
09/02/2010US20100221175 Antibody Therapy
09/02/2010US20100219335 Liquid Chromatography-Mass Spectrometry Analysis of Samples Using Ionic Eluent Comprising a Volatile Ionic Salt
09/02/2010CA2772648A1 Antibodies specifically directed to the soluble form of ctla-4
09/02/2010CA2753567A1 Immunogenic composition
09/02/2010CA2753438A1 Antibodies containing therapeutic tpo/epo mimetic peptides
09/01/2010EP2224012A1 Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
09/01/2010EP2224008A2 Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
09/01/2010EP2224000A1 Antibody and use thereof
09/01/2010EP2223998A1 Peptides that can bind to scurfin and uses thereof
09/01/2010EP2223997A1 Method for producing multiple modifications in the chromosome of gram-negative bacteria and salmonella strains which are deficient in c-di-gmp synthesis obtained by said method
09/01/2010EP2223937A1 Polypeptides for the prevention or treatment of malaria
09/01/2010EP2223935A2 Compounds and methods for treatment and diagnosis of chlamydial infection
09/01/2010EP2223934A1 Methods for inhibiting influenza virus infection and their drugs
09/01/2010EP2223933A1 Genes encoding major capsid protein l1 of human papilloma viruses
09/01/2010EP2223701A1 Pharmaceutical composition for cancer treatment
09/01/2010EP2223700A1 Transfection of blood cells with mRNA for immune stimulation and gene therapy
09/01/2010EP2222836A1 Method for producing dendritic cells
1 ... 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 ... 1823